Skip Navigation

International Immunology 2009 21(1):NP; doi:10.1093/intimm/dxn138
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Int. Immunol.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2009. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

IN THIS ISSUE


    CRTH2 antagonism blocks skin inflammation
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
Here, Boehme et al. (p. 1) examine ovalbumin-induced murine atopic dermatitis treated with an antagonist of CRTH2 (chemoattractant receptor homologous molecule expressed on Th2 cells) — one of the PGD2 receptors —and show decreased cutaneous inflammation and antigen-specific antibody production, suggesting a pivotal role for this receptor. The authors then describe specific effects on dendritic cell functions.


    F. novicida disrupts STAT1 signalling
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
Francisella novicida models tularaemia, but the role of signal transducer and activator of transcription 1 (STAT1) in this disease is unknown. Satoskar and colleagues (p. 19) show that STAT1 –/– mice have more-severe pathology than wild-type mice after infection. F. novicida also suppresses a range of functions in macrophages, in particular, IFN production and activation of CD4+ T cells.


    {gamma}c cytokines and survival of CD127+ T cells
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
CD127 (IL-7R{alpha}) is a marker of CD8+ memory cells. Angel and colleagues (p. 29) examine responses to other cytokines that signal via {gamma}c, and show different responses to cell division and anti-apoptotic signals between CD8+CD127+ and CD8+CD127 cells. The authors discuss implications for diseases in which CD127 expression varies, for example cancer and progressive viral infections such as HIV.


    The B-1 cell repertoire is determined by the pre-BCR
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
The skewed repertoire of the enigmatic, phosphatidylcholine-reactive B-1 B cell subset was thought to be due to antigen-driven clonal selection and expansion; however, Karasuyama and colleagues (p. 43) show that the characteristic B-1 cell J-chain usage is established in the foetal liver early in B cell ontogeny and is antigen-independent. The authors also describe possible molecular mechanisms and consequences.


    Two phenotypes of melanoma-specific T cells expand in vitro
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
Tarazona and colleagues (p. 53) examine in vitro expansion of naïve human melanoma-specific CD8+ cells. Some donors’ cultures have low levels of expansion, but show high cytotoxicity and a CD45RA+CCR7 phenotype; other donors’ cultures have higher expansion but are noncytotoxic, with a CD45RACCR7 phenotype. These results have clear importance for generating cells in adoptive immunotherapy.


    Immunodominant epitopes of SARS
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
Severe acute respiratory syndrome (SARS) is potentially a major public-health problem; it is caused by a coronavirus (CoV). Using tetramer-guided epitope mapping, Kwok and colleagues (p. 63) identified four immunodominant HLA-DR0401-restricted epitopes of SARS-CoV in healthy, naïve subjects. These findings are important for future vaccination strategies and the technique can be applied to other emerging pathogens.


    IFN-{gamma} and IL-6 control superantigen-mediated T cell death
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
Some pathogens contain superantigens, which cause excessive activation and death of CD4+ T cells in many diseases. Murakami and colleagues (p. 73) reveal an important role for CD8+ T cell derived IFN-{gamma} in this cell death. The authors also show that IL-6 in the CD8+ cells can suppress this process. This novel axis may represent a therapeutic target.


    FITC-induced skin inflammation requires CRTH2
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
In this article, Boehme et al. (p. 81) examine FITC-induced murine contact sensitivity and undertake gene-expression analysis after treatment with a CRTH2 (chemoattractant receptor homologous molecule expressed on Th2 cells) antagonist. Decreased transcription of a wide range of inflammatory mediators occurred. This correlated with decreased levels of many cytokines and chemokines. The authors conclude that CRTH inhibits multiple pathways.


    Substrate recognition by human chymase
 Top
 CRTH2 antagonism blocks skin...
 F. novicida disrupts STAT1...
 {gamma}c cytokines and survival...
 The B-1 cell repertoire...
 Two phenotypes of melanoma...
 Immunodominant epitopes of SARS
 IFN-{gamma} and IL-6 control...
 FITC-induced skin inflammation...
 Substrate recognition by human...
 
Chymase is a major component of mast cell granules but its substrate range has still not been fully elucidated. Hellman and colleagues (p. 95) use a phage-displayed random nonapeptide library to show that human chymase has a fairly narrow substrate-recognition profile. The results will help predict and identify substrates, and thus suggest novel functions for chymase.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Int. Immunol.:

Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms
Stefen A. Boehme, Edward P. Chen, Karin Franz-Bacon, Roman Sásik, L. James Sprague, Tai Wei Ly, Gary Hardiman, and Kevin B. Bacon
Int. Immunol. 2009 21: 1-17. [Abstract] [FREE Full Text]  

Francisella inhibits STAT1-mediated signaling in macrophages and prevents activation of antigen-specific T cells
Kimberly M. Roth, John S. Gunn, William Lafuse, and Abhay R. Satoskar
Int. Immunol. 2009 21: 19-28. [Abstract] [FREE Full Text]  

IL-2 receptor {gamma} chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127 T cell division and susceptibility to apoptosis
Angela M. Crawley, Tanya Katz, Karl Parato, and Jonathan B. Angel
Int. Immunol. 2009 21: 29-42. [Abstract] [FREE Full Text]  

The skewed heavy-chain repertoire in peritoneal B-1 cells is predetermined by the selection via pre-B cell receptor during B cell ontogeny in the fetal liver
Soichiro Yoshikawa, Yohei Kawano, Yoshiyuki Minegishi, and Hajime Karasuyama
Int. Immunol. 2009 21: 43-52. [Abstract] [FREE Full Text]  

Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells
Javier G. Casado, Olga DelaRosa, Graham Pawelec, Esther Peralbo, Esther Duran, Fernando Barahona, Rafael Solana, and Raquel Tarazona
Int. Immunol. 2009 21: 53-62. [Abstract] [FREE Full Text]  

Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
Junbao Yang, Eddie James, Michelle Roti, Laurie Huston, John A. Gebe, and William W. Kwok
Int. Immunol. 2009 21: 63-71. [Abstract] [FREE Full Text]  

IFN-{gamma} expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death
Toru Atsumi, Masae Sato, Daisuke Kamimura, Arisa Moroi, Yoichiro Iwakura, Ulrich A. K. Betz, Akihiko Yoshimura, Mika Nishihara, Toshio Hirano, and Masaaki Murakami
Int. Immunol. 2009 21: 73-80. [Abstract] [FREE Full Text]  

A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation
Stefen A. Boehme, Karin Franz-Bacon, Edward P. Chen, Roman Sásik, L. James Sprague, Tai Wei Ly, Gary Hardiman, and Kevin B. Bacon
Int. Immunol. 2009 21: 81-93. [Abstract] [FREE Full Text]  

The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile
Mattias K. Andersson, Mattias Enoksson, Maike Gallwitz, and Lars Hellman
Int. Immunol. 2009 21: 95-104. [Abstract] [FREE Full Text]  




This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Int. Immunol.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?